|
|
 |
|
| | |
| | | | | |
gene
|
|
PR:000003862 |
alpha-2-HS-glycoprotein
|
AHSG
|
"A protein that is a translation product of the human AHSG gene or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:P02765 |
alpha-2-HS-glycoprotein (human)
|
hAHSG
|
"An alpha-2-HS-glycoprotein that is encoded in the genome of human." [PRO:DNx, UniProtKB:P02765]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052898 |
alpha-2-HS-glycoprotein N-glycosylated 1 (human)
|
hAHSG/NGlyco:1
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G00912UN." [GlyGen:P02765-1, PMID:22171320, PMID:24841998, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052899 |
alpha-2-HS-glycoprotein N-glycosylated 2 (human)
|
hAHSG/NGlyco:2
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G06247RL." [GlyGen:P02765-1, PMID:22171320, PMID:24841998, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052900 |
alpha-2-HS-glycoprotein N-glycosylated 3 (human)
|
hAHSG/NGlyco:3
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G08293MJ." [GlyGen:P02765-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052901 |
alpha-2-HS-glycoprotein N-glycosylated 4 (human)
|
hAHSG/NGlyco:4
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G10486CT." [GlyGen:P02765-1, PMID:22171320, PMID:24841998, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052902 |
alpha-2-HS-glycoprotein N-glycosylated 5 (human)
|
hAHSG/NGlyco:5
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G22140GZ. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G22140GZ." [GlyGen:P02765-1, PMID:19838169, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052903 |
alpha-2-HS-glycoprotein N-glycosylated 6 (human)
|
hAHSG/NGlyco:6
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G27947YN." [GlyGen:P02765-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052904 |
alpha-2-HS-glycoprotein N-glycosylated 7 (human)
|
hAHSG/NGlyco:7
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G36131WL. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G36131WL." [GlyGen:P02765-1, PMID:19838169, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052905 |
alpha-2-HS-glycoprotein N-glycosylated 8 (human)
|
hAHSG/NGlyco:8
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G40926MX. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G40926MX." [GlyGen:P02765-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052906 |
alpha-2-HS-glycoprotein N-glycosylated 9 (human)
|
hAHSG/NGlyco:9
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G59626AS." [GlyGen:P02765-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052907 |
alpha-2-HS-glycoprotein N-glycosylated 10 (human)
|
hAHSG/NGlyco:10
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G84467IZ. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G84467IZ." [GlyGen:P02765-1, PMID:6833285, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052908 |
alpha-2-HS-glycoprotein N-glycosylated 11 (human)
|
hAHSG/NGlyco:11
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G85144OK. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G85144OK." [GlyGen:P02765-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052909 |
alpha-2-HS-glycoprotein N-glycosylated 12 (human)
|
hAHSG/NGlyco:12
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G88374WZ." [GlyGen:P02765-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052910 |
alpha-2-HS-glycoprotein N-glycosylated 13 (human)
|
hAHSG/NGlyco:13
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G94917XT." [GlyGen:P02765-1, PMID:22171320, PMID:24841998, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052911 |
alpha-2-HS-glycoprotein N-glycosylated 14 (human)
|
hAHSG/NGlyco:14
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G95865ZB. Example: UniProtKB:P02765-1, Asn-156, MOD:00160~GNO:G95865ZB." [GlyGen:P02765-1, PMID:22171320, PMID:24841998, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052912 |
alpha-2-HS-glycoprotein N-glycosylated 15 (human)
|
hAHSG/NGlyco:15
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G00912UN." [GlyGen:P02765-1, PMID:22171320, PMID:24841998, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052913 |
alpha-2-HS-glycoprotein N-glycosylated 16 (human)
|
hAHSG/NGlyco:16
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G06247RL." [GlyGen:P02765-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052914 |
alpha-2-HS-glycoprotein N-glycosylated 17 (human)
|
hAHSG/NGlyco:17
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G08293MJ." [GlyGen:P02765-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052915 |
alpha-2-HS-glycoprotein N-glycosylated 18 (human)
|
hAHSG/NGlyco:18
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G10486CT." [GlyGen:P02765-1, PMID:22171320, PMID:24841998, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052916 |
alpha-2-HS-glycoprotein N-glycosylated 19 (human)
|
hAHSG/NGlyco:19
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G22140GZ. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G22140GZ." [GlyGen:P02765-1, PMID:19838169, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052917 |
alpha-2-HS-glycoprotein N-glycosylated 20 (human)
|
hAHSG/NGlyco:20
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G27947YN." [GlyGen:P02765-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052918 |
alpha-2-HS-glycoprotein N-glycosylated 21 (human)
|
hAHSG/NGlyco:21
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G29068FM." [GlyGen:P02765-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052919 |
alpha-2-HS-glycoprotein N-glycosylated 22 (human)
|
hAHSG/NGlyco:22
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G36131WL. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G36131WL." [GlyGen:P02765-1, PMID:19838169, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052920 |
alpha-2-HS-glycoprotein N-glycosylated 23 (human)
|
hAHSG/NGlyco:23
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G54992WG. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G54992WG." [GlyGen:P02765-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052921 |
alpha-2-HS-glycoprotein N-glycosylated 24 (human)
|
hAHSG/NGlyco:24
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G59626AS." [GlyGen:P02765-1, PMID:22171320, PMID:24841998, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052922 |
alpha-2-HS-glycoprotein N-glycosylated 25 (human)
|
hAHSG/NGlyco:25
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G84467IZ. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G84467IZ." [GlyGen:P02765-1, PMID:6833285, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052923 |
alpha-2-HS-glycoprotein N-glycosylated 26 (human)
|
hAHSG/NGlyco:26
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G85144OK. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G85144OK." [GlyGen:P02765-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052924 |
alpha-2-HS-glycoprotein N-glycosylated 27 (human)
|
hAHSG/NGlyco:27
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G88374WZ." [GlyGen:P02765-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052925 |
alpha-2-HS-glycoprotein N-glycosylated 28 (human)
|
hAHSG/NGlyco:28
|
"An alpha-2-HS-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-176 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P02765-1, Asn-176, MOD:00160~GNO:G94917XT." [GlyGen:P02765-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052926 |
alpha-2-HS-glycoprotein O-glycosylated 1 (human)
|
hAHSG/OGlyco:1
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-196 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Ser-196, MOD:00002~GNO:G43417UB." [GlyGen:P02765-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052927 |
alpha-2-HS-glycoprotein O-glycosylated 2 (human)
|
hAHSG/OGlyco:2
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-256 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G17015OC. Example: UniProtKB:P02765-1, Ser-256, MOD:00002~GNO:G17015OC." [GlyGen:P02765-1, PMID:26598643, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052928 |
alpha-2-HS-glycoprotein O-glycosylated 3 (human)
|
hAHSG/OGlyco:3
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-256 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G65562ZE. Example: UniProtKB:P02765-1, Ser-256, MOD:00002~GNO:G65562ZE." [GlyGen:P02765-1, PMID:6833285, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052929 |
alpha-2-HS-glycoprotein O-glycosylated 4 (human)
|
hAHSG/OGlyco:4
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-280 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G27391WQ. Example: UniProtKB:P02765-1, Ser-280, MOD:00002~GNO:G27391WQ." [GlyGen:P02765-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052930 |
alpha-2-HS-glycoprotein O-glycosylated 5 (human)
|
hAHSG/OGlyco:5
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-280 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P02765-1, Ser-280, MOD:00002~GNO:G29068FM." [GlyGen:P02765-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052931 |
alpha-2-HS-glycoprotein O-glycosylated 6 (human)
|
hAHSG/OGlyco:6
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-280 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G40740AD. Example: UniProtKB:P02765-1, Ser-280, MOD:00002~GNO:G40740AD." [GlyGen:P02765-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052932 |
alpha-2-HS-glycoprotein O-glycosylated 7 (human)
|
hAHSG/OGlyco:7
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-280 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Ser-280, MOD:00002~GNO:G43417UB." [GlyGen:P02765-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052933 |
alpha-2-HS-glycoprotein O-glycosylated 8 (human)
|
hAHSG/OGlyco:8
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-280 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P02765-1, Ser-280, MOD:00002~GNO:G53434XO." [GlyGen:P02765-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052934 |
alpha-2-HS-glycoprotein O-glycosylated 9 (human)
|
hAHSG/OGlyco:9
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-293 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P02765-1, Ser-293, MOD:00002~GNO:G29068FM." [GlyGen:P02765-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052935 |
alpha-2-HS-glycoprotein O-glycosylated 10 (human)
|
hAHSG/OGlyco:10
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-293 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Ser-293, MOD:00002~GNO:G43417UB." [GlyGen:P02765-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052936 |
alpha-2-HS-glycoprotein O-glycosylated 11 (human)
|
hAHSG/OGlyco:11
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-325 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P02765-1, Ser-325, MOD:00002~GNO:G29068FM." [GlyGen:P02765-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052937 |
alpha-2-HS-glycoprotein O-glycosylated 12 (human)
|
hAHSG/OGlyco:12
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-325 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Ser-325, MOD:00002~GNO:G43417UB." [GlyGen:P02765-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052938 |
alpha-2-HS-glycoprotein O-glycosylated 13 (human)
|
hAHSG/OGlyco:13
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-328 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P02765-1, Ser-328, MOD:00002~GNO:G29068FM." [GlyGen:P02765-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052939 |
alpha-2-HS-glycoprotein O-glycosylated 14 (human)
|
hAHSG/OGlyco:14
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-328 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Ser-328, MOD:00002~GNO:G43417UB." [GlyGen:P02765-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052940 |
alpha-2-HS-glycoprotein O-glycosylated 15 (human)
|
hAHSG/OGlyco:15
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-346 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G17015OC. Example: UniProtKB:P02765-1, Ser-346, MOD:00002~GNO:G17015OC." [GlyGen:P02765-1, PMID:26598643, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052941 |
alpha-2-HS-glycoprotein O-glycosylated 16 (human)
|
hAHSG/OGlyco:16
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-346 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P02765-1, Ser-346, MOD:00002~GNO:G29068FM." [GlyGen:P02765-1, PMID:26598643, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052942 |
alpha-2-HS-glycoprotein O-glycosylated 17 (human)
|
hAHSG/OGlyco:17
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-346 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Ser-346, MOD:00002~GNO:G43417UB." [GlyGen:P02765-1, PMID:22171320, PMID:26598643, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052943 |
alpha-2-HS-glycoprotein O-glycosylated 18 (human)
|
hAHSG/OGlyco:18
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-346 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P02765-1, Ser-346, MOD:00002~GNO:G59626AS." [GlyGen:P02765-1, PMID:26598643, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052944 |
alpha-2-HS-glycoprotein O-glycosylated 19 (human)
|
hAHSG/OGlyco:19
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Ser-346 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G65562ZE. Example: UniProtKB:P02765-1, Ser-346, MOD:00002~GNO:G65562ZE." [GlyGen:P02765-1, PMID:6833285, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052945 |
alpha-2-HS-glycoprotein O-glycosylated 20 (human)
|
hAHSG/OGlyco:20
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Thr-197 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Thr-197, MOD:00005~GNO:G43417UB." [GlyGen:P02765-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052946 |
alpha-2-HS-glycoprotein O-glycosylated 21 (human)
|
hAHSG/OGlyco:21
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Thr-202 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Thr-202, MOD:00005~GNO:G43417UB." [GlyGen:P02765-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052947 |
alpha-2-HS-glycoprotein O-glycosylated 22 (human)
|
hAHSG/OGlyco:22
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Thr-270 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G17015OC. Example: UniProtKB:P02765-1, Thr-270, MOD:00005~GNO:G17015OC." [GlyGen:P02765-1, PMID:26598643, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052948 |
alpha-2-HS-glycoprotein O-glycosylated 23 (human)
|
hAHSG/OGlyco:23
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Thr-270 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G23729WG. Example: UniProtKB:P02765-1, Thr-270, MOD:00005~GNO:G23729WG." [GlyGen:P02765-1, PMID:26598643, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052949 |
alpha-2-HS-glycoprotein O-glycosylated 24 (human)
|
hAHSG/OGlyco:24
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Thr-270 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P02765-1, Thr-270, MOD:00005~GNO:G43417UB." [GlyGen:P02765-1, PMID:26598643, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000052950 |
alpha-2-HS-glycoprotein O-glycosylated 25 (human)
|
hAHSG/OGlyco:25
|
"An alpha-2-HS-glycoprotein (human) that has been O-glycosylated at the residue equivalent to Thr-270 of the amino acid sequence represented by UniProtKB:P02765-1, in which the glycan structure is represented by GlyTouCan:G65562ZE. Example: UniProtKB:P02765-1, Thr-270, MOD:00005~GNO:G65562ZE." [GlyGen:P02765-1, PMID:6833285, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000078101 |
alpha-2-HS-glycoprotein acetylated 1 (human)
|
hAHSG/Ac:1
|
"An alpha-2-HS-glycoprotein (human) that has been acetylated on the residue at the position equivalent to Lys-218 of the amino acid sequence represented by UniProtKB:P02765. UniProtKB:P02765, Lys-218, MOD:00723." [IEDB_epitope:1736970, IEDB_epitope:1736971, IEDB_epitope:1736972, IEDB_epitope:1736973, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000078709 |
alpha-2-HS-glycoprotein phosphorylated 1 (human)
|
hAHSG/Phos:1
|
"An alpha-2-HS-glycoprotein (human) that has been phosphorylated on the residue at the position equivalent to Ser-138 of the amino acid sequence represented by UniProtKB:P02765. UniProtKB:P02765, Ser-138, MOD:00046." [IEDB_epitope:2149231, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000078942 |
alpha-2-HS-glycoprotein methylated 1 (human)
|
hAHSG/Me:1
|
"An alpha-2-HS-glycoprotein (human) that has been methylated on the residue at the position equivalent to Cys-219 of the amino acid sequence represented by UniProtKB:P02765. UniProtKB:P02765, Cys-219, MOD:00660." [IEDB_epitope:1004114, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:P24090 |
alpha-2-HS-glycoprotein (rat)
|
rAHSG
|
"An alpha-2-HS-glycoprotein that is encoded in the genome of rat." [OMA:P24090, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:P29699 |
alpha-2-HS-glycoprotein (mouse)
|
mAHSG
|
"An alpha-2-HS-glycoprotein that is encoded in the genome of mouse." [OMA:P29699, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
modification
|
|
PR:000018936 |
alpha-2-HS-glycoprotein, signal peptide removed form
|
AHSG/SigPep-
|
"An alpha-2-HS-glycoprotein that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
modification
|
|
PR:000018937 |
alpha-2-HS-glycoprotein proteolytic cleavage product
|
AHSG/ClvPrd
|
"An alpha-2-HS-glycoprotein that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
